Over Half of Patients Have Suboptimal Response to Statins
Suboptimal responders have increased risk for incident cardiovascular disease
Cardiovascular Disease
Here’s a List of Nitrosamine-Free ARB Medications, According to the FDA
As part of the ongoing safety investigation of potentially carcinogenic impurities detected in angiotensin II receptor blocker (ARB) medications.
Hyperkalemia Ups In-Hospital Mortality in Cardiac Patients
Hyperkalemia vs normokalemia at admission to a cardiac intensive care unit was associated with 44% increased odds of in-hospital mortality, independent of illness severity and renal function.
Statins Plus Intensive SBP Control May Up Survival in Nondiabetic CKD
For nondiabetic CKD patients taking statins, targeting an intensive SBP goal of less than 120 mm significantly reduced the risks for all-cause and cardiovascular mortality by 56% and 71%, respectively, study finds.
Invokana sNDA Seeking Treatment of Chronic Kidney Disease in T2D Patients
Janssen announced the submission of a supplemental New Drug Application (sNDA) to the Food and Drug Administration (FDA) for Invokana (canagliflozin) to reduce the risk of end-stage renal disease and renal or cardiovascular (CV) death in adults with type 2 diabetes and chronic kidney disease.
Statins Cut Risk for Major Vascular Events in Older Patients
Effects seen even among patients older than 75 years, though with less direct evidence of benefit
ACC: Robust Evidence Lacking for Many Cardiovascular Guidelines
Few recommendations in cardiovascular society guidelines supported by evidence from multiple RCTs
Statins Tied to Insulin Resistance, Higher Serum Fasting Insulin
Ever use of statins associated with 38 percent increased risk for incident type 2 diabetes
Spironolactone Has No Effect on LVM in Hemodialysis Patients
Patients treated with the mineralocorticoid receptor antagonist had a higher frequency of moderate hyperkalemia compared with placebo recipients.
Hyperkalemia Worsens Outcomes in Elderly Patients Hospitalized for HF
Elderly patients hospitalized for heart failure who have high serum potassium levels at admission are at increased risk of readmission for heart failure and death.
Next post in Hyperkalemia
